Dreger P, Holtick U, Subklewe M, von Tresckow B, Ayuk F, Wagner E, Wulf G, Marks R, Penack O, Schnetzke U, Koenecke C, von Bonin M, Stelljes M, Glass B, Baldus CD, Vucinic V, Mougiakakos D, Topp M, Schroers R, Wolff D, Thomas S, Kröger N, Bethge WA; German Lymphoma Alliance (GLA); German Stem Cell Transplantation Registry (DRST). Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience. Bone Marrow Transplant. 2023 Feb;58(2):229-232. doi: 10.1038/s41409-022-01867-4. Epub 2022 Nov 22. PMID: 36418916; PMCID: PMC9902271
Eichhorst B, Niemann CU, Kater AP, Fürstenau M, von Tresckow J, Zhang C, Robrecht S, Gregor M, Juliusson G, Thornton P, Staber PB, Tadmor T, Lindström V, da Cunha-Bang C, Schneider C, Poulsen CB, Illmer T, Schöttker B, Nösslinger T, Janssens A, Christiansen I, Baumann M, Frederiksen H, van der Klift M, Jäger U, Leys MBL, Hoogendoorn M, Lotfi K, Hebart H, Gaska T, Koene H, Enggaard L, Goede J, Regelink JC, Widmer A, Simon F, De Silva N, Fink AM, Bahlo J, Fischer K, Wendtner CM, Kreuzer KA, Ritgen M, Brüggemann M, Tausch E, Levin MD, van Oers M, Geisler C, Stilgenbauer S, Hallek M; GCLLSG, the HOVON and Nordic CLL Study Groups, the SAKK, the Israeli CLL Association, and Cancer Trials Ireland. First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia. N Engl J Med. 2023 May 11;388(19):1739-1754. doi: 10.1056/NEJMoa2213093. PMID: 37163621
Derigs P, Bethge WA, Krämer I, Holtick U, von Tresckow B, Ayuk F, Penack O, Vucinic V, von Bonin M, Baldus C, Mougiakakos D, Wulf G, Schnetzke U, Stelljes M, Fante M, Schroers R, Kroeger N, Dreger P; German Lymphoma Alliance and the German Registry for Stem Cell Transplantation. Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation Analysis. Transplant Cell Ther. 2023 Dec;29(12):750-756. doi: 10.1016/j.jtct.2023.09.008. Epub 2023 Sep 13. PMID: 37709204
Rivera D, Cui W, Gao J, Peker D, Zhang QY, Dewar R, Qiu L, Konoplev S, Hu Z, Sasaki K, Hu A, E S, Liu M, Fang H, Wang W, Tang G, Apperley JF, Hochhaus A, Cortes JE, Khoury JD, Medeiros LJ, Jabbour E, Hu S. Aleukemic Chronic Myeloid Leukemia without Neutrophilia and Thrombocytosis at Initial Presentation: a Report from the BCR::ABL1 Pathology Group. Mod Pathol. 2023 Dec 15:100406. doi: 10.1016/j.modpat.2023.100406. Epub ahead of print. PMID: 38104892
Tubío-Santamaría N, Jayavelu AK, Schnoeder TM, Eifert T, Hsu CJ, Perner F, Zhang Q, Wenge DV, Hansen FM, Kirkpatrick JM, Jyotsana N, Lane SW, von Eyss B, Deshpande AJ, Kühn MWM, Schwaller J, Cammann C, Seifert U, Ebstein F, Krüger E, Hochhaus A, Heuser M, Ori A, Mann M, Armstrong SA, Heidel FH. Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia. Mol Cancer. 2023 Dec 4;22(1):196. doi: 10.1186/s12943-023-01907-7. PMID: 38049829; PMCID: PMC10694946
Fleischmann M, Fischer M, Schnetzke U, Fortner C, Kirkpatrick J, Heidel FH, Hochhaus A, Scholl S. Modulation of FLT3-ITD Localization and Targeting of Distinct Downstream Signaling Pathways as Potential Strategies to Overcome FLT3-Inhibitor Resistance. Cells. 2021 Nov 3;10(11):2992. doi: 10.3390/cells10112992. PMID: 34831215; PMCID: PMC8616352
Shalgouny M, Bertz-Lepel J, Fischer V Weikersthal L, Herbin J, Meier-Höfig M, Mücke R, Rohe U, Stauch T, Stoll C, Troeltzsch D, Wittmann S, Kurz O, Naumann R, Huebner J. Introducing a standardized assessment of patients' interest in and usage of CAM in routine cancer care: chances and risks from patients' and physicians' point of view. J Cancer Res Clin Oncol. 2023 Dec;149(18):16575-16587. doi: 10.1007/s00432-023-05182-3. Epub 2023 Sep 16. PMID: 37715831; PMCID: PMC10645655
Rosti G, Brümmendorf TH, Gjertsen BT, Giraldo-Castellano P, Castagnetti F, Gambacorti-Passerini C, Ernst T, Zhao H, Kuttschreuter L, Purcell S, Giles FJ, Hochhaus A. Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study. Leukemia. 2024 Jan;38(1):126-135. doi: 10.1038/s41375-023-02080-y. Epub 2023 Nov 25. PMID: 38007586; PMCID: PMC10776383
Lorenzen S, Götze TO, Thuss-Patience P, Biebl M, Homann N, Schenk M, Lindig U, Heuer V, Kretzschmar A, Goekkurt E, Haag GM, Riera-Knorrenschild J, Bolling C, Hofheinz RD, Zhan T, Angermeier S, Ettrich TJ, Siebenhuener AR, Elshafei M, Bechstein WO, Gaiser T, Loose M, Sookthai D, Kopp C, Pauligk C, Al-Batran SE; AIO and SAKK Study Working Groups. Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial. J Clin Oncol. 2023 Nov 14:JCO2300975. doi: 10.1200/JCO.23.00975. Epub ahead of print. PMID: 37963317
Aldenhoff, F. Aschenbrenner, E. Baum, M. Baumann, W. Bertram, V. Borger, K. Brass, S. Bushuven, A. Conrad, G. Danzer, U. Dittmer, G. Döller, A. Eggert, D. Eichenberger zur Bonsen, A. Encke, M.R. Fischer, U. Förstermann |R. Frankenberger, S. Frantz |C. Friedrich, M. Frosch, W. Georg, T. Greschik, O. Gröne, C. Groß, N. Halama, A. Hasenburg, R. Hecker, S. C. Herpertz, M. Herrmann, H. Hildebrandt, K. Hofmann, J. Holst, G. Hörl, J. Hübner, C. Jassoy, G. Jonitz, J. Jünger, K. Kemmritz, U. Koch-Gromus, I. B. Kopp, S. Krieger, T.-T. Lâm, F. Lammert, H. Lang, M. Leuzinger-Bohleber, G. Matheis, E. D. Munz, A. Mutschler, E. Nagel, G. Nettekoven, T. Niedenthal, F. Niroomand, N. Ouédraogo, F. Paulsen, U. Repschläger, B. Salzberger, T. Schäfer, B. Schlegelberger, S. Schramm, M. Schütz, R. Seifert, M. Sievers, A. Spaic, A. Stallmach, G. Stöcker, R. Strametz, M.-J. Sturm, S. Taubner, U. Teichert, U. Teichgräber, A. Thater, P. Tinnemann, G. Trabert, B. Vajen, B. Vajen, H. Vatter, E. von Hirschhausen, S. Weinbrenner, J. Weis, C. Witte, W. Wohlgemuth: Heilkunst Reloaded, MWV Medizinisch Wissenschaftliche Verlagsgesellschaft; 1. Edition (23. Oktober 2023), ISBN-10 : 3954668262, ISBN-13 : 978-3954668267
Josfeld L, Huebner J; Working Group Prevention and Integrative Oncology in the German Cancer Society. Development and analysis of quality assessment tools for different types of patient information - websites, decision aids, question prompt lists, and videos. BMC Med Inform Decis Mak. 2023 Jun 21;23(1):111. doi: 10.1186/s12911-023-02204-5. PMID: 37344772; PMCID: PMC10283325
Möller J, Josfeld L, Keinki C, Zieglowski N, Büntzel J, Hübner J. The quality of German - language patient decision aids for oncological patients on the internet. BMC Med Inform Decis Mak. 2023 Aug 18;23(1):161. doi: 10.1186/s12911-023-02259-4. PMID: 37596582; PMCID: PMC10436558
Pouyiourou M, Kraft BN, Wohlfromm T, Stahl M, Kubuschok B, Löffler H, Hacker UT, Hübner G, Weiss L, Bitzer M, Ernst T, Schütt P, Hielscher T, Delorme S, Kirchner M, Kazdal D, Ball M, Kluck K, Stenzinger A, Bochtler T, Krämer A. Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial. Nat Commun. 2023 Oct 24;14(1):6761. doi: 10.1038/s41467-023-42400-5. PMID: 37875494; PMCID: PMC10598029
Cross NCP, Ernst T, Branford S, Cayuela JM, Deininger M, Fabarius A, Kim DDH, Machova Polakova K, Radich JP, Hehlmann R, Hochhaus A, Apperley JF, Soverini S. European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia. Leukemia. 2023 Oct 4. doi: 10.1038/s41375-023-02048-y. Epub ahead of print. PMID: 37794101
Cale RP, Hochhaus A: "Oppenheimer" ia a reminder to physicians, scientist to act to prevent nuclear war. The cancer letter, Sept. 29.2023, Vol 49, issute 36
Shalgouny M, Bertz-Lepel J, Fischer V Weikersthal L, Herbin J, Meier-Höfig M, Mücke R, Rohe U, Stauch T, Stoll C, Troeltzsch D, Wittmann S, Kurz O, Naumann R, Huebner J. Introducing a standardized assessment of patients' interest in and usage of CAM in routine cancer care: chances and risks from patients' and physicians' point of view. J Cancer Res Clin Oncol. 2023 Sep 16. doi: 10.1007/s00432-023-05182-3. Epub ahead of print. PMID: 37715831
Lauseker M, Hehlmann R, Hochhaus A, Saußele S. Survival with chronic myeloid leukaemia after failing milestones. Leukemia. 2023 Sep 19. doi: 10.1038/s41375-023-02028-2. Epub ahead of print. PMID: 37726340
Eckardt JN, Bill M, Rausch C, Metzeler K, Spiekermann K, Stasik S, Sauer T, Scholl S, Hochhaus A, Crysandt M, Brümmendorf TH, Krug U, Wörmann B, Hiddemann W, Görlich D, Sauerland C, Steffen B, Einsele H, Neubauer A, Burchert A, Schäfer-Eckart K, Berdel WE, Schliemann C, Krause SW, Hänel M, Hanoun M, Kaufmann M, Fransecky L, Braess J, Ruhnke L, Schetelig J, Middeke JM, Serve H, Baldus CD, Platzbecker U, Müller-Tidow C, Bornhäuser M, Herold T, Thiede C, Röllig C. Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European leukemia net risk classification. Leukemia. 2023 Sep 7. doi: 10.1038/s41375-023-02016-6. Epub ahead of print. PMID: 37679502
Hoppe C, Büntzel J, Paradies K, Rösler M, Hübner J; Working Group Prevention and Integrative Oncology of the German Cancer Society. Psychosocial effects of the corona pandemic on people with cancer: a qualitative study. J Cancer Res Clin Oncol. 2023 Oct;149(13):11031-11039. doi: 10.1007/s00432-023-04970-1. Epub 2023 Jun 20. PMID: 37340188; PMCID: PMC10465636
Hammersen J, Birndt S, Döhner K, Reuken P, Stallmach A, Sauerbrey P, La Rosée F, Pfirrmann M, Fabisch C, Weiss M, Träger K, Bremer H, Russo S, Illerhaus G, Drömann D, Schneider S, La Rosée P, Hochhaus A. The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial. Leukemia. 2023 Sep;37(9):1879-1886. doi: 10.1038/s41375-023-01979-w. Epub 2023 Jul 28. PMID: 37507425; PMCID: PMC10457200
Isfort S, Manz K, Teichmann LL, Crysandt M, Burchert A, Hochhaus A, Saussele S, Kiani A, Göthert JR, Illmer T, Schafhausen P, Al-Ali HK, Stegelmann F, Hänel M, Pfeiffer T, Giagounidis A, Franke GN, Koschmieder S, Fabarius A, Ernst T, Warnken-Uhlich M, Wolber U, Kohn D, Pfirrmann M, Wolf D, Brümmendorf TH; German CML study group. Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study. Ann Hematol. 2023 Aug 18. doi: 10.1007/s00277-023-05394-0. Epub ahead of print. PMID: 37592092
Eifert T, Hsu CJ, Becker AL, Graessle S, Horne A, Bemmann F, Zhang Q, Heuser M, Vasioukhin V, Scholl S, Hochhaus A, Siegerist F, Endlich N, Bullinger L, Lane SW, Haas S, Schnoeder TM, Heidel FH. Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia. Leukemia. 2023 Aug 16. doi: 10.1038/s41375-023-02005-9. Epub ahead of print. PMID: 37587260
Schrenk KG, Weschenfelder W, Spiegel C, Agaimy A, Stöhr R, Hartmann A, Gaßler N, Drescher R, Freesmeyer M, Malouhi A, Bürckenmeyer F, Aschenbach R, Teichgräber U, Kögler C, Vogt M, Hofmann GO, Hochhaus A. Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET-fusion-associated sarcoma. J Cancer Res Clin Oncol. 2023 Aug;149(9):5493-5496. doi: 10.1007/s00432-022-04496-y. Epub 2022 Dec 5. PMID: 36469155; PMCID: PMC10356868
Staupe H, Buentzel J, Keinki C, Buentzel J, Huebner J. Systematic analysis of mistletoe prescriptions in clinical studies. J Cancer Res Clin Oncol. 2023 Aug;149(9):5559-5571. doi: 10.1007/s00432-022-04511-2. Epub 2022 Dec 9. PMID: 36481925; PMCID: PMC10356894
Atallah E, Mauro MJ, Hochhaus A, Boquimpani C, Minami Y, Maheshwari VK, Saini L, Corbin R, Réa D. Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors. J Cancer Res Clin Oncol. 2023 Aug;149(9):6247-6262. doi: 10.1007/s00432-022-04562-5. Epub 2023 Jan 28. PMID: 36707445; PMCID: PMC10356870
Keck M, Hübner J, Büntzel J. "I do not hear you!": hearing-impaired cancer patients report their communication experiences. J Cancer Res Clin Oncol. 2023 Aug;149(9):6557-6567. doi: 10.1007/s00432-023-04634-0. Epub 2023 Feb 13. PMID: 36780054; PMCID: PMC9924207
Schmidt A, Bernhardt C, Bürkle D, Fries S, Hannig CV, Jentsch-Ullrich K, Josting A, Kreher S, Reiser M, Steinmetz HT, Tesch H, Terner S, Schulte A, Crodel CC, Palandri F, Heidel FH. Diagnosis and treatment of MPN in real life: exploratory and retrospective chart review including 960 MPN patients diagnosed with ET or MF in Germany. J Cancer Res Clin Oncol. 2023 Aug;149(10):7197-7206. doi: 10.1007/s00432-023-04669-3. Epub 2023 Mar 8. PMID: 36884118; PMCID: PMC10374473
Hübner J: Kommentar zu "Tumortherapie: Beipackzettel gehen am Patienten vorbei". Dtsch Med Wochenschr 2023; 148; 2023. Thieme; 877-878
Hack V, Josfeld L, Hübner J, Keinki C, Büntzel J. Decision-making by cancer patients and the role of a counselling facility for complementary and alternative medicine: a cohort study. J Cancer Res Clin Oncol. 2023 Jul;149(7):2903-2913. doi: 10.1007/s00432-022-04178-9. Epub 2022 Jul 11. PMID: 35819526; PMCID: PMC10314849
Colditz C, Keinki C, Huebner J. Self-help management of patients undergoing chemotherapy: analysis of the online forum of the women's self-help association against cancer. Breast Cancer. 2023 Jul 7. doi: 10.1007/s12282-023-01481-2. Epub ahead of print. PMID: 37420142
Halwas N, Griebel L, Huebner J. eHealth literacy, Internet and eHealth service usage: a survey among cancer patients and their relatives. J Cancer Res Clin Oncol. 2017 Nov;143(11):2291-2299. doi: 10.1007/s00432-017-2475-6. Epub 2017 Jul 11. PMID: 28699035
Schaefer C, Hübner J: Leitlinien zur Förderung der Patientenbeteiligung und -Information. Günster et al. (Hrsg.) Versorgungs-Report Leitlinien - Evidenz für die Praxis. ISBN: 978-3-95466-800-7
Boesenecker SJ, Mathies V, Buentzel J, Huebner J. How can counselling by family physicians on nutrition and physical activity be improved: trends from a survey in Germany. J Cancer Res Clin Oncol. 2023 Jul;149(7):3335-3347. doi: 10.1007/s00432-022-04233-5. Epub 2022 Aug 6. PMID: 35932301; PMCID: PMC10314832
Boesenecker SJ, Mathies V, Buentzel J, Huebner J. Nutrition and physical activity in cancer patients: a survey on their information sources. J Cancer Res Clin Oncol. 2022 Aug 22. doi: 10.1007/s00432-022-04282-w. Epub ahead of print. PMID: 35994117
Keinki C, Ahmadi E, Kastrati K, Zomorodbakhsch B, Hübner J; Working Group Prevention and Integrative Oncology of the German Cancer Society (PRIO). Cancer Patient Motives and Expectations on Non-medical Practitioners. In Vivo. 2022 Sep-Oct;36(5):2505-2513. doi: 10.21873/invivo.12986. PMID: 36099132; PMCID: PMC946393
Josfeld L, Huebner J; Working Group Prevention and Integrative Oncology in the German Cancer Society. Development and analysis of quality assessment tools for different types of patient information - websites, decision aids, question prompt lists, and videos. BMC Med Inform Decis Mak. 2023 Jun 21;23(1):111. doi: 10.1186/s12911-023-02204-5. PMID: 37344772
Hoppe C, Büntzel J, Paradies K, Rösler M, Hübner J; Working Group Prevention and Integrative Oncology of the German Cancer Society. Psychosocial effects of the corona pandemic on people with cancer: a qualitative study. J Cancer Res Clin Oncol. 2023 Jun 20. doi: 10.1007/s00432-023-04970-1. Epub ahead of print. PMID: 37340188
Georgi JA, Stasik S, Eckardt JN, Zukunft S, Hartwig M, Röllig C, Middeke JM, Oelschlägel U, Krug U, Sauer T, Scholl S, Hochhaus A, Brümmendorf TH, Naumann R, Steffen B, Einsele H, Schaich M, Burchert A, Neubauer A, Schäfer-Eckart K, Schliemann C, Krause SW, Hänel M, Noppeney R, Kaiser U, Baldus CD, Kaufmann M, Müller-Tidow C, Platzbecker U, Berdel WE, Serve H, Ehninger G, Bornhäuser M, Schetelig J, Kroschinsky F, Thiede C; Study Alliance Leukemia (SAL). UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome. Blood Cancer J. 2023 May 26;13(1):88. doi: 10.1038/s41408-023-00858-y. PMID: 37236968; PMCID: PMC1022002
Chen Y, Möbius S, Riege K, Hoffmann S, Hochhaus A, Ernst T, Rudolph KL. Genetic separation of chronic myeloid leukemia stem cells from normal hematopoietic stem cells at single-cell resolution. Leukemia. 2023 May 26. doi: 10.1038/s41375-023-01929-6. Epub ahead of print. PMID: 37237078
Supplement to: Eichhorst B, Niemann CU, Kater AP, et al. First-line venetoclax combinations in chronic lymphocytic
leukemia. N Engl J Med 2023;388:1739-54. DOI: 10.1056/NEJMoa2213093
Kühnel C, Salomo S, Pagiatakis H, Hübner J, Seifert P, Freesmeyer M, Gühne F. Medical Students’ and Radiology Technician Trainees’ eHealth Literacy and Hygiene Awareness—Asynchronous and Synchronous Digital Hand Hygiene Training in a Single-Center Trial. Healthcare. 2023; 11(10):1475. https://doi.org/10.3390/healthcare11101475
Wurschi GW, Güllmar D, Gaßler N, Clement J, Kesselmeier M, Müller-Wurschi JJ, Settmacher U, Mothes H, Helfritzsch H, Liebe Y, Franiel T, Mäurer MA, Ernst T, Nicolay NH, Wittig A. Planning adaptive treatment by longitudinal response assessment implementing MR imaging, liquid biopsy and analysis of microenvironment during neoadjuvant treatment of rectal cancer (PRIMO). Medicine (Baltimore). 2023 Apr 25;102(17):e33575. doi: 10.1097/MD.0000000000033575. PMID: 37115093; PMCID: PMC10146036
Hübner J, Keinki C, Büntzel J. Komplementäre und alternative Medizin – eine Option bei chronischen Schmerzpatienten? [Complementary and alternative medicine-An option for chronic pain patients?]. Schmerz. 2023 May 8. German. doi: 10.1007/s00482-023-00719-4. Epub ahead of print. PMID: 37154977
Hinze A, Rinke J, Crodel CC, Möbius S, Schäfer V, Heidel FH, Hochhaus A, Ernst T. Molecular-defined clonal evolution in patients with classical myeloproliferative neoplasms. Br J Haematol. 2023 Jul;202(2):308-317. doi: 10.1111/bjh.18834. Epub 2023 May 4. PMID: 37139709
Hauptmann M, Kutschan S, Hübner J, Dörfler J. Bioenergy therapies as a complementary treatment: a systematic review to evaluate the efficacy of bioenergy therapies in relieving treatment toxicities in patients with cancer. J Cancer Res Clin Oncol. 2023 Jun;149(6):2607-2619. doi: 10.1007/s00432-022-04362-x. Epub 2022 Sep 27. PMID: 36166091; PMCID: PMC10129966
Keinki C, Rudolph I, Wozniak T, Pietsch R, Margolina M, Garcia I, Mayr-Welschlau K, Schmidt T, Hübner J. A virtual dance sport class for cancer patients: the trainer perspective. J Cancer Res Clin Oncol. 2023 Mar;149(3):1079-1083. doi: 10.1007/s00432-022-03913-6. Epub 2022 Mar 7. PMID: 35253086; PMCID: PMC9984500
Bargehr B, Fischer von Weikersthal L, Junghans C, Zomorodbakhsch B, Stoll C, Prott FJ, Fuxius S, Micke O, Hübner J, Büntzel J, Hoppe C. Sense of coherence and its context with demographics, psychological aspects, lifestyle, complementary and alternative medicine and lay aetiology. J Cancer Res Clin Oncol. 2023 Apr 20. doi: 10.1007/s00432-023-04760-9. Epub ahead of print. PMID: 37079052
Mickoleit F, Jörke C, Richter R, Rosenfeldt S, Markert S, Rehberg I, Schenk AS, Bäumchen O, Schüler D, Clement JH. Long-Term Stability, Biocompatibility, and Magnetization of Suspensions of Isolated Bacterial Magnetosomes. Small. 2023 Feb 17:e2206244. doi: 10.1002/smll.202206244. Epub ahead of print. PMID: 36799182
Réa D, Boquimpani C, Mauro MJ, Minami Y, Allepuz A, Maheshwari VK, D'Alessio D, Wu Y, Lawrance R, Narbutas S, Sharf G, Hochhaus A. Health-related quality of life of patients with resistant/intolerant chronic phase chronic myeloid leukemia treated with asciminib or bosutinib in the phase 3 ASCEMBL trial. Leukemia. 2023 May;37(5):1060-1067. doi: 10.1038/s41375-023-01888-y. Epub 2023 Apr 14. PMID: 37069326
Wagenknecht A, Dörfler J, Freuding M, Josfeld L, Huebner J. Homeopathy effects in patients during oncological treatment: a systematic review. J Cancer Res Clin Oncol. 2023 May;149(5):1785-1810. doi: 10.1007/s00432-022-04054-6. Epub 2022 Jun 22. PMID: 35731274; PMCID: PMC10097733
Ritschel ML, Hübner J, Wurm-Kuczera R, Büntzel J. Phytotherapy known and applied by head-neck cancer patients and medical students to treat oral discomfort in Germany: an observational study. J Cancer Res Clin Oncol. 2023 May;149(5):2057-2070. doi: 10.1007/s00432-022-04200-0. Epub 2022 Jul 23. PMID: 35870011; PMCID: PMC10097744
Retzlaff T, Dörfler J, Kutschan S, Freuding M, Hübner J. The benefits of vitamin A as a complementary treatment for oncology patients: a systematic review. J Cancer Res Clin Oncol. 2023 May;149(5):2157-2177. doi: 10.1007/s00432-022-04224-6. Epub 2022 Aug 16. PMID: 35972692
Brandt F, Schneider N, Altmann U, Strauß B, Hübner J, Keinki C. Psychometrische Eigenschaften des Qualiskope-A zur Messung der Patientenzufriedenheit mit der ambulant-ärztlichen Behandlung: Einsatz in der Onkologie und Übertragbarkeit auf die stationäre Versorgung [Psychometric Properties of the Qualiskope-A for Measuring Patient Satisfaction with Outpatient Medical Treatment: Use in Oncology and Transferability to Inpatient Care]. Gesundheitswesen. 2023 Apr 7. German. doi: 10.1055/a-2016-7948. Epub ahead of print. PMID: 3702841
Frietsch JJ, Flossdorf S, Beck JF, Kröger N, Fleischhauer K, Dreger P, Schetelig J, Bornhäuser M, Hochhaus A, Hilgendorf I. Outcomes after allogeneic haematopoietic stem cell transplantation in young adults in Germany. Br J Haematol. 2023 Apr;201(2):308-318. doi: 10.1111/bjh.18610. Epub 2022 Dec 27. PMID: 36573337
Hauptmann L, Midic D, Eigendorff F, Malouhi A, Theis B, Kißler H, Rödel J, Prims F, Hochhaus A, Scholl S, Schnetzke U. Staphylococcus intermedius infection with splenic abscesses in a patient with acute lymphoblastic leukemia. Ann Hematol. 2023 Apr 4. doi: 10.1007/s00277-023-05208-3. Epub ahead of print. PMID: 37014448
Hochhaus A, Ströbel P, Höffken K: Myeloproliferative Neoplasien – eine heterogene Entität mit vielen Ähnlichkeiten. Onkologie 29, 278–280 (2023), https://doi.org/10.1007/s00761-023-01330-z
Siebert R, Schuh A, Ott G, Cree IA, Du MQ, Ferry J, Hochhaus A, Naresh KN, Solary E, Khoury JD. Response to the Comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors. Leukemia. 2023 May;37(5):1170-1172. doi: 10.1038/s41375-023-01872-6. Epub 2023 Mar 27. PMID: 36973349
Tober R, Schnetzke U, Fleischmann M, Yomade O, Schrenk K, Hammersen J, Glaser A, Thiede C, Hochhaus A, Scholl S: Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia. J Cancer Res Clin Oncol. 2023 Apr;149(4):1569-1583. doi: 10.1007/s00432-022-03995-2. Epub 2022 May 18. PMID: 35583829; PMCID: PMC10020242
Mauro MJ, Hughes TP, Kim DW, Rea D, Cortes JE, Hochhaus A, Sasaki K, Breccia M, Talpaz M, Ottmann O, Minami H, Goh YT, DeAngelo DJ, Heinrich MC, Gómez-García de Soria V, le Coutre P, Mahon FX, Janssen JJWM, Deininger M, Shanmuganathan N, Geyer MB, Cacciatore S, Polydoros F, Agrawal N, Hoch M, Lang F. Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results. Leukemia. 2023 May;37(5):1048-1059. doi: 10.1038/s41375-023-01860-w. Epub 2023 Mar 22. PMID: 36949155
Kröger N., Gagelmann N, Hilgendorf I: Allogene Stammzelltransplantation bei myeloproliferativen Neoplasien. Onkologie 2023, 29: 339–345, https://doi.org/10.1007/s00761-023-01329-6
Hübner J, Prott FJ, Büntzel J, Micke O, Keinki C: Wer zahlt für komplementäre und alternative Medizin? Forum https://doi.org/10.1007/s12312-023-01187-8, published online 15 March 2023
Keinki C, Rudolph I, Wozniak T, Pietsch R, Margolina M, Garcia I, Mayr-Welschlau K, Schmidt T, Hübner J: A virtual dance sport class for cancer patients: the trainer perspective. J Cancer Res Clin Oncol. 2023 Mar;149(3):1079-1083. doi: 10.1007/s00432-022-03913-6. Epub 2022 Mar 7. PMID: 35253086; PMCID: PMC9984500
DiNardo CD, Hochhaus A, Frattini MG, Yee K, Zander T, Krämer A, Chen X, Ji Y, Parikh NS, Choi J, Wei AH: A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome. J Cancer Res Clin Oncol. 2023 Mar;149(3):1145-1158. doi: 10.1007/s00432-022-03983-6. Epub 2022 Mar 30. PMID: 35353219
Stegelmann F, Teichmann LL, Heidel FH, Crodel CC, Ernst T, Kreil S, Reiter A, Otten S, Schauer S, Körber RM, Kricheldorf K, Isfort S, Döhner H, Brümmendorf TH, Griesshammer M, Döhner K, Koschmieder S: Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN). Leukemia. 2023 Feb 24. doi: 10.1038/s41375-023-01837-9. Epub ahead of print. PMID: 36828867
Giebel S, Labopin M, Schroeder T, Swoboda R, Maertens J, Bourhis JH, Grillo G, Salmenniemi U, Hilgendorf I, Kröger N, Poiré X, Cornelissen JJ, Arat M, Savani B, Spyridonidis A, Nagler A, Mohty M: Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Am J Hematol. 2023 Jan 10. doi: 10.1002/ajh.26825. Epub ahead of print. PMID: 36626592
Atallah E, Mauro MJ, Hochhaus A, Boquimpani C, Minami Y, Maheshwari VK, Saini L, Corbin R, Réa D: Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors. J Cancer Res Clin Oncol. 2023 Jan 28. doi: 10.1007/s00432-022-04562-5. Epub ahead of print. PMID: 36707445
Ernst T, Hochhaus A: Chronische myeloische Leukämie. Onkologie 29, 305–314 (2023), https://doi.org/10.1007/s00761-022-01290-w
Späth C, Peter N, Opitz B, Florschütz A, Reifenrath K, Zojer N, Scholl S, Pönisch W, Heyn S, Vucinic V, Hochhaus A, Aul C, Giagounidis A, Balleisen L, Oldenkott B, Staib P, Kiehl M, Schütte W, Naumann R, Eimermacher H, Dörken B, Sauerland C, Lengfelder E, Hiddemann W, Wörmann B, Müller-Tidow C, Serve H, Schliemann C, Hehlmann R, Berdel WE, Pfirrmann M, Krug U, Hoffmann VS: Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study. Ann Hematol. 2023 Jan 25. doi: 10.1007/s00277-023-05087-8. Epub ahead of print. PMID: 36695874
Goldmann M, Schmidt F, Cseresnyés Z, Orasch T, Jahreis S, Hartung S, Figge MT, von Lilienfeld-Toal M, Heinekamp T, Brakhage AA: The Lipid Raft-Associated Protein Stomatin Is Required for Accumulation of Dectin-1 in the Phagosomal Membrane and for Full Activity of Macrophages against Aspergillus fumigatus. mSphere. 2023 Jan 31:e0052322. doi: 10.1128/msphere.00523-22. Epub ahead of print. PMID: 36719247
Giesen N, Sprute R, Rüthrich M, Khodamoradi Y, Mellinghoff SC, Beutel G, Lueck C, Koldehoff M, Hentrich M, Sandherr M, von Bergwelt-Baildon M, Wolf HH, Hirsch HH, Wörmann B, Cornely OA, Köhler P, Schalk E, von Lilienfeld-Toal M: COVID-19 guideline panel of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). 2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy. Eur J Cancer. 2021 Apr;147:154-160. doi: 10.1016/j.ejca.2021.01.033. Epub 2021 Feb 10. PMID: 33676266; PMCID: PMC7874914
Schuster FS, Nyvlt P, Heeren P, Spies C, Adam MF, Schenk T, Brunkhorst FM, Janka G, La Rosée P, Lachmann C, Lachmann G: Differential Diagnosis of Hyperferritinemia in Critically Ill Patients. J Clin Med. 2022 Dec 27;12(1):192. doi: 10.3390/jcm12010192. PMID: 36614993; PMCID: PMC9821140
Ruhnke L, Röllig C, Herold S, Sauer T, Brandts CH, Steffen B, Schäfer-Eckart K, Krause SW, Hänel M, Reichle A, Scholl S, Neubauer A, Mikesch JH, Schetelig J, Stölzel F, Kramer M, Haake A, Frimmel J, Krämer A, Schlenk R, Platzbecker U, Serve H, Baldus CD, Müller-Tidow C, Aust D, Bornhäuser M, Ehninger G, Thiede C: Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3-ITD mutations: results of the SAL MIDOKIT trial. Haematologica. 2023 Feb 9. doi: 10.3324/haematol.2022.281636. Epub ahead of print. PMID: 36779591
Mickoleit F, Jörke C, Richter R, Rosenfeldt S, Markert S, Rehberg I, Schenk AS, Bäumchen O, Schüler D, Clement JH: Long-Term Stability, Biocompatibility, and Magnetization of Suspensions of Isolated Bacterial Magnetosomes. Small 2023, DOI: 10.1002/smll.202206244
Brioli A, Gengenbach L, Mancuso K, Binder M, Ernst T, Heidel FH, Stauch T, Zamagni E, Hilgendorf I, Hochhaus A, Engelhardt M, von Lilienfeld-Toal M. Pomalidomide combinations are a safe and effective option after daratumumab failure. J Cancer Res Clin Oncol. 2023 Aug;149(9):6569-6574. doi: 10.1007/s00432-023-04637-x. Epub 2023 Feb 13. PMID: 36781500; PMCID: PMC10356885
Heidel FH., Crodel CC, Kreipe HH: Primäre Myelofibrose. Onkologie 29, 315–322 (2023), https://doi.org/10.1007/s00761-022-01253-1
Dörfler J, Freuding M, Zaiser C, Büntzel J, Keinki C, Käsmann L, Hübner J: Umbrella review: Summary of findings for acupuncture as treatment for radiation-induced xerostomia. Head Neck. 2023 Feb 13. doi: 10.1002/hed.27297. Epub ahead of print. PMID: 36779370
Keck M, Hübner J, Büntzel J. "I do not hear you!": hearing-impaired cancer patients report their communication experiences. J Cancer Res Clin Oncol. 2023 Feb 13. doi: 10.1007/s00432-023-04634-0. Epub ahead of print. PMID: 36780054
Radich JP, Wall M, Branford S, Campbell CD, Chaturvedi S, DeAngelo DJ, Deininger M, Guinney J, Hochhaus A, Hughes TP, Kantarjian HM, Larson RA, Li S, Maegawa R, Mishra K, Obourn V, Pinilla-Ibarz J, Purkayastha D, Sadek I, Saglio G, Shrestha A, White BS, Druker BJ: Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis. Haematologica. 2023 Feb 2. doi: 10.3324/haematol.2022.281878. Epub ahead of print. PMID: 36727397
Hochhaus A, Réa D, Boquimpani C, Minami Y, Cortes JE, Hughes TP, Apperley JF, Lomaia E, Voloshin S, Turkina A, Kim D, Abdo A, Fogliatto LM, le Coutre P, Sasaki K, Kim D, Saussele S, Annunziata M, Chaudhri N, Chee L, García-Gutiérrez V, Kapoor S, Allepuz A, Quenet S, VBédoucha V, Mauro MJ: Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37, 617–626 (2023) https://doi.org/10.1038/s41375-023-01829-9
Rummelt C, Grishina O, Schmoor C, Crysandt M, Heuser M, Götze KS, Schlenk RF, Döhner K, Salih HR, Heil G, Müller-Tidow C, Brugger W, Kündgen A, De Wit M, Giagounidis A, Scholl S, Neubauer A, Krauter J, Bug G, Al-Ali HK, Wäsch R, Becker H, May AM, Duyster J, Hackanson B, Ganser A, Döhner H, Lübbert M.:Activity of decitabine combined with all-trans retinoic acid in oligoblastic AML: Results from a randomized 2x2 phase II trial (DECIDER). Haematologica. 2023 Jan 5. doi: 10.3324/haematol.2022.282258. Epub ahead of print. PMID: 36601981
Kayser S, Kramer M, Martínez-Cuadrón D, Grenet J, Metzeler KH, Sustkova Z, Luskin MR, Brunner AM, Elliott MA, Gil C, Marini SC, Ráčil Z, Cetkovsky P, Novak J, Perl AE, Platzbecker U, Stölzel F, Ho AD, Thiede C, Stone RM, Röllig C, Montesinos P, Schlenk RF, Levis MJ: Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study. Haematologica. 2022 Apr 1;107(4):836-843. doi: 10.3324/haematol.2021.278645. PMID: 34348451; PMCID: PMC8968900
Ernst T, Hochhaus A: Chronische myeloische Leukämie. Onkologie 29, 305–314 (2023). https://doi.org/10.1007/s00761-022-01290-w
Krege S, Hübner J: Integrative Medizin in der Uroonkologie. Die Urologie | Ausgabe 1/2023
Hübner J, Keinki C, Münstedt K: Alternativmedizin in der Uroonkologie. Die Urologie | Ausgabe 1/2023
Bauer-Büntzel C, Büntzel J, Zomorodbakhsch B, Keinki C: Phytotherapie in der Uroonkologie. Die Urologie | Ausgabe 1/2023
Schmidt L, Mathies V, von Grundherr J: Praxisrelevante Ernährungsempfehlungen in der Uroonkologie. Die Urologie | Ausgabe 1/2023
Niederwieser D, Lan T, Krahl R, Heinicke T, Maschmeyer G, Al‑Ali HK, Schwind S, Jentzsch M, Cross M, Kahl C, Wolf HH, Sayer H, Schulze A, Dreger P,· Hegenbart U, · Krämer A, Junghanss C, · Mügge LO, Hähling D, Hirt C, Späth C, Peter N, Opitz B, · Florschütz A, Reifenrath K, Zojer N, Scholl S, · Pönisch W, Heyn S, Vucinic V, Hochhaus A, Aul C, Giagounidis A, Balleisen L, Oldenkott B, Staib P, Kiehl M, Schütte W, Naumann R, Eimermacher H, Dörken B, Sauerland C, Lengfelder E, Hiddemann W, Wörmann B, Muller‑Tidow C, Serve H, Schliemann C, Hehlmann R, E. Berdel WE, Pfirrmann M, Utz Krug39,44 · Hoffmann VS: Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study. Ann Hematol (2023). https://doi.org/10.1007/s00277-023-05087-8
Hochhaus A, Ott G, Siebert R: WHO-Klassifikation 2022 chronischer myeloproliferativer Erkrankungen. Onkologie 2023, 29:287–295https://doi.org/10.1007/s00761-023-01308-x
Huebner J, Muecke R, Micke O, Prott FJ, Josfeld L, Büntzel J, Büntzel J; Working Group Prevention, Integrative Oncology of the German Cancer Society. Lay etiology concepts of cancer patients do not correlate with their usage of complementary and/or alternative medicine. J Cancer Res Clin Oncol. 2023 Aug;149(9):6067-6074. doi: 10.1007/s00432-022-04528-7. Epub 2023 Jan 18. PMID: 36653538; PMCID: PMC10356643
Mathies V, Schmidt L, Reudelsterz C, Hübner J. (2023): Ernährung bei besonderen Folgeerscheinungen der Tumorerkrankung. In: Schmoll, HJ. (eds) Kompendium Internistische Onkologie . Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46764-0_341-1
Giebel S, Labopin M, Schroeder T, Swoboda R, Maertens J, Bourhis JH, Grillo G, Salmenniemi U, Hilgendorf I, Kröger N, Poiré X, Cornelissen JJ, Arat M, Savani B, Spyridonidis A, Nagler A, Mohty M: Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Am J Hematol. 2023 Jan 10. doi: 10.1002/ajh.26825. Epub ahead of print. PMID: 36626592
Kouka M, Landgraf J, Büntzel J, Kaftan H, Böger D, Mueller A, Schultze-Mosgau S, Ernst T, Guntinas-Lichius O: Sterberisiko für Mundhöhlen- und Oropharynxkarzinome in Thüringen: eine bevölkerungsbasierte Analyse [Mortality risk for oral and oropharyngeal carcinomas in Thuringia: a population-based analysis]. Laryngorhinootologie. 2023 Jan 5. German. doi: 10.1055/a-1976-9815. Epub ahead of print. PMID: 36603817
Appel TM, Stein C, Brandt C, Rödel J, Frietsch JJ, Miethke J, Hochhaus A, Hilgendorf I. Isolation of Hafnia paralvei co-harbouring blaNDM-1 and blaVIM-1 in a woman who underwent allogeneic hematopoietic stem cell transplantation. Infection. 2023 Aug;51(4):1161-1164. doi: 10.1007/s15010-022-01976-8. Epub 2023 Jan 3. PMID: 36595211; PMCID: PMC10352390
Hübner J, Münstedt K, Micke O, Prott FJ, Schmidt T, Büntzel J, Keinki C. Komplementäre oder alternative Medizin in der Onkologie : Chancen oder Risiken? [Complementary or alternative medicine in oncology : Chances or risks?]. Inn Med (Heidelb). 2023 Jan;64(1):3-9. German. doi: 10.1007/s00108-022-01452-3. Epub 2023 Jan 3. PMID: 36594968